2D chemical structure

Rosuvastatin (Crestor) 2D structure

Role
Drug
Mechanism class
Statin / HMG-CoA
Indication
Hyperlipidemia / high-intensity statin · FDA/EMA
Structure source
Catalog seed (external identifier on file)
PubChem CID
446157
FDA / EMA
FDA/EMA
ClinicalTrials.gov
rosuvastatin LDL
Regulatory status
Approved · FDA/EMA · ClinicalTrials.gov · ClinicalTrials.gov

Hand-written analysis

Mechanism

로수바스타틴도 HMG-CoA 환원효소 저해로 LDL-C를 내립니다. 고강도이며 친수성 쪽으로 분류됩니다. OATP1B1 변이가 노출에 영향을 줍니다.

Medicinal chemistry

피리미딘 설폰아마이드 코어입니다. 아토르바스타틴의 피롤과 케모타입이 다릅니다.

Indication · context

고강도 스타틴 선택지입니다. PCSK9 제제와는 표적 층이 다릅니다.

SMILES

CC(C)C1=NC(=NC(=C1C2=CC=C(C=C2)F)C(=O)N[C@@H](CC3=CC=C(C=C3)S(=O)(=O)N)C(=O)O)C(C)(C)O

Tags

statinFDAapprovedLDL-Cpotent

Related compounds

External IDs · BioMoa

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Rosuvastatin (Crestor) structure · Statin / HMG-CoA | StructureMoa